Browse the complete record of transactions filed by Belldegrun Arie, Director. Insider active across 4 companies, notably Allogene Therapeutics, Inc.. Aggregated, 9 disclosures have been logged. Total volume traded: €3.4m. The latest transaction was disclosed on 10 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Arie Belldegrun is a Board Member at Allogene Therapeutics, Inc. and UroGen Pharma Ltd. He plays a key role in the governance of these biopharmaceutical companies, contributing to the definition of their strategy and guiding their research efforts. His expertise in biotechnology is a valuable asset.